ALBA THERAPEUTICS CORPORATION

Basic Information

2400 BOSTON STREET
SUITE 334
BALTIMORE, MD, 21224

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    Amount: $265,312.00

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeabil ...

    STTR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government